Cim Investment Management Inc Amgen Inc Transaction History

Cim Investment Management Inc

$321 Million
Q2 2024

A detailed history of Cim Investment Management Inc transactions in Amgen Inc stock. As of the latest transaction made, Cim Investment Management Inc holds 2,521 shares of AMGN stock, worth $820,030. This represents 0.25% of its overall portfolio holdings.

Number of Shares

2,521

Previous 2,545 0.94%

Holding current value

$820,030

Previous $723,000 8.85%

% of portfolio

0.25%

Previous 0.22%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	SELL	$262.75 - $319.31 $6,306 - $7,663	-24 Reduced 0.94%	2,521 $787,000
Q3 2023 Nov 14, 2023	SELL	$218.65 - $271.46 $12,025 - $14,930	-55 Reduced 2.12%	2,545 $683,000
Q2 2023 Aug 09, 2023	BUY	$214.27 - $253.37 $1,285 - $1,520	6 Added 0.23%	2,600 $577,000
Q1 2023 May 16, 2023	BUY	$225.79 - $275.2 $26,191 - $31,923	116 Added 4.68%	2,594 $627,000
Q4 2022 Feb 14, 2023	SELL	$229.03 - $291.01 $15,115 - $19,206	-66 Reduced 2.59%	2,478 $650,000
Q2 2022 Sep 02, 2022	SELL	$230.71 - $256.74 $2,999 - $3,337	-13 Reduced 0.51%	2,544 $619,000
Q1 2022 May 17, 2022	SELL	$219.27 - $242.57 $438 - $485	-2 Reduced 0.08%	2,557 $618,000
Q4 2021 May 19, 2022	SELL	$198.88 - $227.6 $518,082 - $592,898	-2,605 Reduced 50.45%	2,559 $576,000
Q4 2021 Feb 02, 2022	BUY	$198.88 - $227.6 $508,933 - $582,428	2,559 Added 98.23%	5,164 $1.13 Million
Q3 2021 Nov 15, 2021	SELL	$212.27 - $248.7 $2,971 - $3,481	-14 Reduced 0.53%	2,605 $554,000
Q2 2021 Aug 13, 2021	SELL	$233.58 - $259.14 $14,248 - $15,807	-61 Reduced 2.28%	2,619 $638,000
Q1 2021 May 20, 2021	SELL	$221.91 - $258.6 $20,637 - $24,049	-93 Reduced 3.35%	2,680 $667,000
Q4 2020 Feb 17, 2021	SELL	$216.38 - $257.67 $8,871 - $10,564	-41 Reduced 1.46%	2,773 $638,000
Q3 2020 Nov 16, 2020	SELL	$234.65 - $260.95 $6,570 - $7,306	-28 Reduced 0.99%	2,814 $715,000
Q1 2020 May 22, 2020	BUY	$182.24 - $241.7 $16,948 - $22,478	93 Added 3.38%	2,842 $576,000
Q3 2019 Nov 14, 2019	SELL	$174.11 - $208.62 $575,781 - $689,906	-3,307 Reduced 54.61%	2,749 $532,000
Q2 2019 Aug 08, 2019	BUY	$166.7 - $195.41 $37,174 - $43,576	223 Added 3.82%	6,056 $1.12 Million
Q1 2019 May 13, 2019	BUY	$180.87 - $203.88 $433,002 - $488,088	2,394 Added 69.61%	5,833 $1.11 Million
Q4 2018 Feb 05, 2019	SELL	$178.4 - $208.25 $662,756 - $773,648	-3,715 Reduced 51.93%	3,439 $669,000
Q3 2018 Nov 09, 2018	SELL	$185.29 - $208.89 $555 - $626	-3 Reduced 0.04%	7,154 $1.48 Million
Q2 2018 Aug 07, 2018	SELL	$166.05 - $186.51 $33,874 - $38,048	-204 Reduced 2.77%	7,157 $1.32 Million
Q1 2018 May 10, 2018	SELL	$169.43 - $198.0 $31,175 - $36,432	-184 Reduced 2.44%	7,361 $1.26 Million
Q4 2017 Feb 13, 2018	BUY	$168.79 - $188.59 $1.27 Million - $1.42 Million	7,545	7,545 $1.31 Million

Others Institutions Holding AMGN

# of Institutions

3,085

Shares Held

417M

Call Options Held

7.24M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $174B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cim Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cim Investment Management Inc with notifications on news.

Account

Cim Investment Management Inc Amgen Inc Transaction History